Monte Rosa Therapeutics Stock (GLUE)
Track Monte Rosa Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
GLUE
Monte Rosa Therapeutics
healthcare
$19.16
▲ +15.18 (+380.45%) past year
Market Cap
$1.62B
P/E Ratio
—
1Y Return
+380.45%
EPS (TTM)
-$1.63
Read the latest TheStreet Pro articles mentioning Monte Rosa Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning GLUE yet.
Daily Diary Mentions
0 mentionsNo diary mentions for GLUE yet.